Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 3/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.30 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.30 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12175648 | 0.79 | ALOX5 (0.48) | ALDH1A1ALOX5PRKDCPLA2G10PLA2G2A | |
| SCHEMBL21157902 | 0.78 | ALDH1A1 (0.45) | ALDH1A1MAPTPRKDCPLA2G2APLA2G4A | |
| SCHEMBL17425731 | 0.78 | ALOX5 (0.47) | ALDH1A1ALOX5PRKDCPLA2G10PLA2G2A | |
| SCHEMBL16133306 | 0.78 | ALOX5 (0.47) | ALDH1A1ALOX5PRKDCPLA2G10PLA2G2A | |
| SCHEMBL17057260 | 0.78 | ALOX5 (0.47) | ALDH1A1ALOX5PRKDCPLA2G10PLA2G2A | |
| SCHEMBL17057263 | 0.76 | ALOX5 (0.48) | ALDH1A1ALOX5PRKDCPLA2G10PLA2G2A | |
| SCHEMBL17057281 | 0.76 | ALOX5 (0.48) | ALDH1A1ALOX5PRKDCPLA2G10PLA2G2A | |
| SCHEMBL17057308 | 0.76 | ALOX5 (0.48) | ALDH1A1ALOX5PRKDCPLA2G10PLA2G2A | |
| SCHEMBL12175731 | 0.76 | ALOX5 (0.50) | ALDH1A1ALOX5PRKDCPLA2G10PLA2G2A | |
| SCHEMBL16133248 | 0.75 | ALOX5 (0.44) | ALDH1A1ALOX5PRKDCPLA2G10PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10804469-B2 | Charge transport material, organic electroluminescent element, and illumination device, display device, or light-emitting device characterized by using said element | UDC IRELAND LIMITED (IE) | 2020-10-13 | — | — | US | disclosed |
| US-20150069332-A1 | CHARGE TRANSPORT MATERIAL, OGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE, DISPLAY DEVICE, OR LIGHT-EMITTING DEVICE CHARACTERIZED BY USING SAID ELEMENT | UDC IRELAND LIMITED (IE) | 2015-03-12 | — | — | US | disclosed |
| US-20150069332-A1 | CHARGE TRANSPORT MATERIAL, OGANIC ELECTROLUMINESCENT ELEMENT, AND ILLUMINATION DEVICE, DISPLAY DEVICE, OR LIGHT-EMITTING DEVICE CHARACTERIZED BY USING SAID ELEMENT | UDC IRELAND LIMITED (IE) | 2015-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10804469-B2 | Charge transport material, organic electroluminescent element, and illumination device, display device, or light-emitting device characterized by using said element | ITGAL, ITGA1, ITGB1 | ALDH1A1 1035/4885MAPT 2591/4885ALOX5 4247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.